Statistics for Cetuximab for Immunotherapy-Refractory/Ineligible Cutaneous Squamous Cell Carcinoma
Total visits
| views | |
|---|---|
| Cetuximab for Immunotherapy-Refractory/Ineligible Cutaneous Squamous Cell Carcinoma | 6 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 2 |
| March 2025 | 1 |
| April 2025 | 1 |
File Visits
| views | |
|---|---|
| java.util.UUID:b30bf402-a560-4c47-90c4-43eecdcf0f0a | 17 |
| java.util.UUID:dd0dccff-b179-41c3-b456-958dfb99e29e | 16 |
| cancers-15-03180.pdf | 9 |
| java.util.UUID:dea754f3-c56d-49f3-a014-5a1e7755f8fb | 6 |
Top country views
| views | |
|---|---|
| United States | 5 |
| Australia | 1 |
Top city views
| views | |
|---|---|
| Franklin | 2 |
| Baltimore | 1 |
| Melbourne | 1 |
| New York | 1 |
| St Louis | 1 |